$ Value
$1.5M
Shares
2,521
Price
$584
Filed
Dec 4
Insider
Name
Lagarde Michel
Title
Executive Vice President & COO
CIK
0001518973
Roles
Transaction Details
Transaction Date
2025-12-03
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
65,480
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $581.90 to $582.33, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $583.03 to $583.96, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $584.00 to $584.533, inclusive. | The option vested in two equal installments on August 29, 2017 and 2020.
Filing Info
Lagarde Michel's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-04 | TMO | M | $2.0M |
| 2025-12-04 | TMO | M | $2.9M |
| 2025-12-04 | TMO | ▼ | $12.4M |
| 2025-12-04 | TMO | M | $0 |
| 2025-12-04 | TMO | M | $0 |
| 2025-12-03 | TMO | M | $7.2M |
| 2025-12-03 | TMO | ▼ | $17.2M |
| 2025-12-03 | TMO | ▼ | $1.5M |
| 2025-12-03 | TMO | M | $0 |
| 2025-12-02 | TMO | M | $3.8M |
Other Insiders at TMO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| JOHNSON JENNIFER M | — | — | 2026-03-28 |
| SPERLING SCOTT M | — | — | 2026-03-28 |
| Lynch Karen S | — | — | 2026-03-28 |
| WEISLER DION J | — | — | 2026-03-28 |
| Keith R. Alexandra | — | — | 2026-03-28 |